In this report, the breast imaging market is segmented into mammography, breast ultrasound, breast MRI coils and Molecular Breast Imaging (MBI). Within the mammography market, segmentation consisting of analog mammography, computed radiography (CR) mammography, digital radiography (DR) mammography and digital breast tomosynthesis (DBT) further breaks down the market.
The breast ultrasound market comprises manual breast ultrasound and automated breast ultrasound and the MBI market is composed of gamma imaging and positron emission mammography (PEM).
Market growth will be driven by the development of new imaging technologies as well as the aging population, which typically requires an above-average number of imaging procedures. In 2015, the largest segment in the breast imaging market was DBT. Most analog devices have already been converted to DR mammography units; thus, the significant growth in DR mammography that was seen is previous years has begun to slow.
Furthermore, with the disappearance of analog and takeover of DR mammography the incentive to switch to CR mammography has become greatly reduced. With two out of four segments in decline and another undergoing the process of becoming a replacement market, the only segment remaining to drive market growth is the DBT market.
Key Topics Covered:
1. Research Methodology
2. Product Assessment
2.1 Product Portfolios 2.2 Regulatory Issues And Recalls 2.3 Clinical Trials 2.3.1 Bayer 2.3.2 Bracco 2.3.3 Carestream Health 2.3.4 Fujifilm 2.3.5 Ge Healthcare 2.3.6 Guerbet 2.3.7 Hologic 2.3.8 Lantheus Medical Imaging 2.3.9 Philips Healthcare 2.3.10 Siemens Healthcare 2.3.11 Toshiba Medical Systems
3. Breast Imaging Market
3.1 Market Overview 3.2 Market Analysis And Forecast 3.2.1 Total Mammography Market 3.2.2 Total Molecular Breast Imaging Market 3.2.3 Total Breast Ultrasound Market 3.2.4 Mri Coil Market 3.3 Drivers And Limiters 3.4 Competitive Market Share Analysis